Laporan Laba Rugi (TTM)
Laporan Laba Rugi Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2022 01-01 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2023 01-01 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,344 | 1,112 | 1,343 | 1,448 | 1,425 | 1,515 | 1,490 | 1,424 | 1,446 | 1,471 | 1,422 | 1,506 | 1,501 | 1,473 | 1,460 | 1,394 | 1,398 | 1,323 | 1,326 | 1,323 |
| Change (%) | -17.26 | 20.83 | 7.79 | -1.62 | 6.38 | -1.68 | -4.41 | 1.50 | 1.73 | -3.33 | 5.89 | -0.28 | -1.86 | -0.88 | -4.54 | 0.26 | -5.38 | 0.28 | -0.22 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 270 | 230 | 296 | 331 | 348 | 350 | 344 | 331 | 345 | 353 | 345 | 370 | 362 | 381 | 378 | 358 | 359 | 329 | 334 | 339 |
| Change (%) | -14.71 | 28.69 | 11.81 | 5.17 | 0.64 | -1.67 | -3.92 | 4.33 | 2.26 | -2.27 | 7.42 | -2.33 | 5.33 | -0.81 | -5.43 | 0.53 | -8.46 | 1.53 | 1.60 | |
| % of Revenue | 20.06 | 20.68 | 22.03 | 22.85 | 24.43 | 23.11 | 23.11 | 23.23 | 23.87 | 24.00 | 24.26 | 24.61 | 24.10 | 25.87 | 25.89 | 25.65 | 25.72 | 24.88 | 25.19 | 25.65 |
| Gross Operating Profit | 1,074 | 882 | 1,047 | 1,117 | 1,077 | 1,165 | 1,146 | 1,094 | 1,101 | 1,118 | 1,077 | 1,135 | 1,139 | 1,092 | 1,082 | 1,036 | 1,038 | 994 | 992 | 984 |
| Change (%) | -17.91 | 18.77 | 6.66 | -3.63 | 8.24 | -1.68 | -4.55 | 0.64 | 1.56 | -3.67 | 5.40 | 0.38 | -4.14 | -0.91 | -4.23 | 0.17 | -4.31 | -0.13 | -0.83 | |
| % of Revenue | 79.94 | 79.32 | 77.97 | 77.15 | 75.57 | 76.89 | 76.89 | 76.77 | 76.13 | 76.00 | 75.74 | 75.39 | 75.90 | 74.13 | 74.11 | 74.35 | 74.28 | 75.12 | 74.81 | 74.35 |
| SG&A | 1,251 | 1,174 | 1,287 | 1,291 | 1,186 | 983 | 956 | 918 | 905 | 920 | 880 | 935 | 939 | 914 | 906 | 863 | 862 | 793 | 776 | 766 |
| Change (%) | -6.19 | 9.60 | 0.32 | -8.13 | -17.09 | -2.72 | -4.03 | -1.35 | 1.66 | -4.35 | 6.24 | 0.39 | -2.66 | -0.93 | -4.70 | -0.08 | -8.04 | -2.13 | -1.24 | |
| % of Revenue | 93.11 | 105.58 | 95.77 | 89.13 | 83.23 | 64.87 | 64.18 | 64.43 | 62.62 | 62.58 | 61.92 | 62.13 | 62.55 | 62.03 | 62.01 | 61.90 | 61.69 | 59.95 | 58.51 | 57.91 |
| R&D | 54 | 50 | 45 | 37 | 37 | 64 | 69 | 75 | 71 | 65 | 66 | 68 | 70 | 46 | 44 | 42 | 45 | 50 | 53 | 51 |
| Change (%) | -6.88 | -10.46 | -18.81 | 1.68 | 70.72 | 8.24 | 8.74 | -4.87 | -8.72 | 1.44 | 2.79 | 4.04 | -34.92 | -3.22 | -4.31 | 5.05 | 12.93 | 5.63 | -4.79 | |
| % of Revenue | 4.02 | 4.53 | 3.35 | 2.53 | 2.61 | 4.19 | 4.61 | 5.25 | 4.92 | 4.41 | 4.63 | 4.50 | 4.69 | 3.11 | 3.04 | 3.04 | 3.19 | 3.81 | 4.01 | 3.83 |
| OpEx | 1,581 | 1,458 | 1,643 | 1,680 | 1,599 | 1,402 | 1,377 | 1,334 | 1,333 | 1,350 | 1,302 | 1,385 | 1,383 | 1,352 | 1,337 | 1,272 | 1,270 | 1,182 | 1,178 | 1,174 |
| Change (%) | -7.79 | 12.68 | 2.28 | -4.85 | -12.30 | -1.78 | -3.12 | -0.10 | 1.27 | -3.55 | 6.41 | -0.19 | -2.25 | -1.09 | -4.88 | -0.16 | -6.89 | -0.33 | -0.34 | |
| % of Revenue | 117.67 | 131.14 | 122.30 | 116.04 | 112.24 | 92.52 | 92.43 | 93.67 | 92.19 | 91.78 | 91.56 | 92.01 | 92.10 | 91.74 | 91.54 | 91.22 | 90.84 | 89.38 | 88.84 | 88.73 |
| Operating Income | -237 | -346 | -300 | -232 | -174 | 113 | 113 | 90 | 113 | 121 | 120 | 120 | 119 | 122 | 124 | 122 | 128 | 140 | 148 | 149 |
| Change (%) | 45.83 | -13.46 | -22.46 | -24.98 | -165.02 | -0.47 | -20.05 | 25.19 | 7.15 | -0.84 | 0.24 | -1.40 | 2.71 | 1.44 | -0.91 | 4.65 | 9.61 | 5.40 | 0.76 | |
| % of Revenue | -17.67 | -31.14 | -22.30 | -16.04 | -12.24 | 7.48 | 7.57 | 6.33 | 7.81 | 8.22 | 8.44 | 7.99 | 7.90 | 8.26 | 8.46 | 8.78 | 9.16 | 10.62 | 11.16 | 11.27 |
| Interest Expense | -110 | -125 | -115 | -111 | -106 | -97 | -93 | -92 | -90 | -89 | -88 | -89 | -85 | -83 | -83 | -83 | -84 | -85 | -86 | -85 |
| Change (%) | 14.08 | -8.39 | -3.64 | -4.01 | -8.44 | -4.77 | -0.83 | -1.53 | -1.75 | -0.37 | 0.25 | -4.13 | -2.20 | -0.31 | 0.66 | 1.13 | 0.71 | 1.20 | -0.99 | |
| % of Revenue | -8.17 | -11.27 | -8.54 | -7.64 | -7.45 | -6.41 | -6.21 | -6.44 | -6.25 | -6.04 | -6.22 | -5.89 | -5.66 | -5.64 | -5.68 | -5.99 | -6.04 | -6.43 | -6.48 | -6.43 |
| Net Income | -2,359 | -359 | -311 | -263 | -185 | 35 | 37 | 20 | 32 | 30 | 31 | 33 | 33 | 44 | 46 | 46 | 52 | 56 | 59 | 61 |
| Change (%) | -84.76 | -13.49 | -15.41 | -29.56 | -119.03 | 4.87 | -46.35 | 61.02 | -5.64 | 3.89 | 6.62 | -0.48 | 32.18 | 5.06 | -1.15 | 14.64 | 7.90 | 4.25 | 3.30 | |
| % of Revenue | -175.51 | -32.33 | -23.15 | -18.17 | -13.01 | 2.33 | 2.48 | 1.39 | 2.21 | 2.05 | 2.20 | 2.22 | 2.21 | 2.98 | 3.16 | 3.27 | 3.74 | 4.27 | 4.44 | 4.59 |
Source: Capital IQ
